Loading clinical trials...
Loading clinical trials...
A Phase 4, Open Label Study To Assess The Bronchopulmonary Pharmacokinetics Of Anidulafungin And Voriconazole Following Intravenous Administration In Healthy Subjects
The purpose of this study is to provide anidulafungin and voriconazole to healthy subjects to determine the drug concentration in the lung.
Age
18 - 55 years
Sex
ALL
Healthy Volunteers
Yes
Pfizer Investigational Site
Hartford, Connecticut, United States
Start Date
September 1, 2008
Primary Completion Date
October 1, 2008
Completion Date
October 1, 2008
Last Updated
February 9, 2010
24
ACTUAL participants
anidulafungin and voriconazole
DRUG
Lead Sponsor
Pfizer
NCT05421858
NCT03748069
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06244979